flupenthixol has been researched along with Recrudescence in 29 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (65.52) | 18.7374 |
| 1990's | 7 (24.14) | 18.2507 |
| 2000's | 1 (3.45) | 29.6817 |
| 2010's | 1 (3.45) | 24.3611 |
| 2020's | 1 (3.45) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Hu, L; Huang, M; Li, D; Shen, L; Xiao, X | 1 |
| Enterman, JH; van Dijk, D | 1 |
| Müller, P; Nerenz, H; Schaefer, E | 1 |
| Dencker, SJ; Lepp, M; Malm, U | 2 |
| Johnson, DA; Ludlow, JM; Pasterski, G; Street, K; Taylor, RD | 1 |
| Berkowitz, R; Eberlein-Fries, R; Kuipers, L; Leff, J; Sturgeon, D | 1 |
| Ranta, J; Wistedt, B | 1 |
| Palmstierna, T; Wistedt, B | 1 |
| Jørgensen, A; Wiles, D; Wistedt, B | 1 |
| Wistedt, B | 1 |
| Aaskoven, O; Ahlfors, UG; Baastrup, PC; Dencker, SJ; Elgen, K; Lingjaerde, O; Pedersen, V; Schou, M | 1 |
| Gerlach, J | 1 |
| Halliday, J | 1 |
| Budde, G; Greger, J; Haug, HJ; Jakobitsch, A; Osterheide, M; Pach, J; Sprenger, R; Tegeler, J | 1 |
| Franken-Hiep, K; Horn, R; Osterheider, M | 1 |
| Bejerot, S; Bodlund, O | 1 |
| Buppanharun, W; Chakrabhand, ML; Chanpattana, W; Kirdcharoen, N; Kitaroonchai, W; Kongsakon, R; Sackeim, HA; Techakasem, P; Tuntirungsee, Y | 1 |
| Arató, M; Erdós, A | 1 |
| Johnson, DA | 2 |
| Angst, J; Margoses, N; Woggon, B | 1 |
| Krska, J; Sampath, G; Shah, A; Soni, SD | 1 |
| Crockett, GT; Grant, S; Greene, JG; Kershaw, PW; Livingston, MG; Mahmood, Z; McCreadie, RG; Todd, NA; Watt, JA; Wiles, D | 1 |
| Johnstone, EC | 1 |
| Crow, TJ; Johnson, AL; Johnstone, EC; MacMillan, JF | 1 |
| Binchy, I; Bourke, S; Fahy, J; Fitzgerald, MX; McCarthy, A | 1 |
| Barnes, R; Ennis, J; Spenser, H | 1 |
| Gottfries, CG; Green, L | 1 |
2 review(s) available for flupenthixol and Recrudescence
| Article | Year |
|---|---|
Depot neuroleptics in relapse prevention: advantages and disadvantages.
Topics: Adult; Antipsychotic Agents; Delayed-Action Preparations; Dystonia; Female; Flupenthixol; Humans; Male; Middle Aged; Patient Readmission; Recurrence; Schizophrenia; Treatment Refusal | 1995 |
[Current status of neuroleptic long term treatment of schizophrenia].
Topics: Ambulatory Care; Antiparkinson Agents; Chronic Disease; Delayed-Action Preparations; Flupenthixol; Fluphenazine; Fluspirilene; Humans; Long-Term Care; Penfluridol; Placebos; Prognosis; Recurrence; Schizophrenia; Tranquilizing Agents | 1975 |
11 trial(s) available for flupenthixol and Recrudescence
| Article | Year |
|---|---|
Psychosocial relevance and benefit of neuroleptic maintenance: experience in the United Kingdom.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Attitude to Health; Clinical Trials as Topic; Delayed-Action Preparations; Family; Family Therapy; Female; Flupenthixol; Fluphenazine; Follow-Up Studies; Health Education; Humans; Interview, Psychological; Life Change Events; Male; Middle Aged; Outcome and Process Assessment, Health Care; Psychotherapy, Group; Recurrence; Schizophrenia; Schizophrenic Psychology; Stress, Psychological; United Kingdom | 1984 |
Comparative double-blind study of flupenthixol decanoate and fluphenazine decanoate in the treatment of patients relapsing in a schizophrenic symptomatology.
Topics: Adult; Aged; Chronic Disease; Clinical Trials as Topic; Depression; Double-Blind Method; Flupenthixol; Fluphenazine; Humans; Middle Aged; Random Allocation; Recurrence; Schizophrenia; Thioxanthenes; Time Factors | 1983 |
Depressive symptoms in chronic schizophrenic patients after withdrawal of long-acting neuroleptics.
Topics: Adult; Depressive Disorder; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Random Allocation; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes; Tranquilizing Agents | 1983 |
A depot neuroleptic withdrawal study. Plasma concentration of fluphenazine and flupenthixol and relapse frequency.
Topics: Delayed-Action Preparations; Female; Flupenthixol; Fluphenazine; Humans; Male; Recurrence; Schizophrenia; Substance Withdrawal Syndrome; Thioxanthenes; Time Factors | 1982 |
A depot neuroleptic withdrawal study. A controlled study of the clinical effects of the withdrawal of depot fluphenazine decanoate and depot flupenthixol decanoate in chronic schizophrenic patients.
Topics: Adult; Aged; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Placebos; Recurrence; Schizophrenia; Substance Withdrawal Syndrome; Thioxanthenes | 1981 |
Flupenthixol decanoate in recurrent manic-depressive illness. A comparison with lithium.
Topics: Bipolar Disorder; Depressive Disorder; Flupenthixol; Humans; Lithium; Recurrence; Thioxanthenes | 1981 |
[Non-compliance and lack of indications for depot treatment as reasons for exclusion from adequate prevention of recurrence].
Topics: Double-Blind Method; Flupenthixol; Humans; Patient Selection; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Tranquilizing Agents; Treatment Outcome; Treatment Refusal | 1996 |
Continuation ECT in treatment-resistant schizophrenia: a controlled study.
Topics: Adult; Antipsychotic Agents; Combined Modality Therapy; Electroconvulsive Therapy; Female; Flupenthixol; Humans; Male; Middle Aged; Prospective Studies; Recurrence; Schizophrenia; Single-Blind Method | 1999 |
[Experience with depot neuroleptics].
Topics: Adolescent; Adult; Clinical Trials as Topic; Delayed-Action Preparations; Drug Evaluation; Drug Therapy, Combination; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Recurrence; Schizophrenia; Thioxanthenes | 1979 |
The Scottish first episode schizophrenia study. VII. Two-year follow-up. Scottish Schizophrenia Research Group.
Topics: Clinical Trials as Topic; Double-Blind Method; Family; Flupenthixol; Follow-Up Studies; Humans; Pimozide; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Scotland; Social Adjustment; Thioxanthenes | 1989 |
A randomised controlled trial of prophylactic neuroleptic treatment.
Topics: Adolescent; Adult; Aged; Antipsychotic Agents; Chlorpromazine; Clinical Trials as Topic; Female; Flupenthixol; Follow-Up Studies; Haloperidol; Humans; Male; Middle Aged; Pimozide; Random Allocation; Recurrence; Schizophrenia; Time Factors; Trifluoperazine | 1986 |
16 other study(ies) available for flupenthixol and Recrudescence
| Article | Year |
|---|---|
The combination therapy with esomeprazole and flupenthixol/melitracen in symptom improvement of erosive gastritis complicated with negative feelings compared with Esomeprazole alone.
Topics: Aged; Anthracenes; Anxiety; Combined Modality Therapy; Depression; Emotions; Esomeprazole; Female; Flupenthixol; Gastric Mucosa; Gastritis; Humans; Male; Middle Aged; Recurrence; Stomach Ulcer; Treatment Outcome | 2020 |
The curious case of a catatonic patient.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Catatonia; Combined Modality Therapy; Delayed-Action Preparations; Diagnosis, Differential; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Electroconvulsive Therapy; Flupenthixol; Follow-Up Studies; Humans; Lorazepam; Male; Recurrence; Schizophrenia, Catatonic; Schizophrenia, Paranoid | 2011 |
[The risk of rehospitalisation during therapy with atypical and typical neuroleptics--a contribution to differential indication].
Topics: Administration, Oral; Adult; Ambulatory Care; Antipsychotic Agents; Delayed-Action Preparations; Female; Flupenthixol; Germany; Humans; Male; Middle Aged; Patient Readmission; Psychiatric Status Rating Scales; Recurrence; Retrospective Studies; Risk; Schizophrenia; Treatment Outcome | 2002 |
Do schizophrenics well adapted in the community need neuroleptics? A depot neuroleptic withdrawal study.
Topics: Ambulatory Care; Antipsychotic Agents; Chronic Disease; Clopenthixol; Delayed-Action Preparations; Flupenthixol; Follow-Up Studies; Humans; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Social Adjustment; Substance Withdrawal Syndrome; Time Factors | 1980 |
The discontinuance of maintenance neuroleptic therapy in chronic schizophrenic patients: drug and social consequences.
Topics: Adult; Antipsychotic Agents; Chronic Disease; Drug Administration Schedule; Female; Flupenthixol; Fluphenazine; Humans; Male; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Adjustment; Thioxanthenes | 1983 |
Dyskinesia and withdrawal from alcohol.
Topics: Adult; Alcoholism; Bipolar Disorder; Diagnosis, Dual (Psychiatry); Drug Administration Schedule; Dyskinesia, Drug-Induced; Female; Flupenthixol; Humans; Neurologic Examination; Psychoses, Alcoholic; Recurrence; Substance Withdrawal Syndrome; Tranquilizing Agents | 1994 |
[Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)].
Topics: Adult; Aged; Ambulatory Care; Cost Savings; Dopamine Antagonists; Female; Flupenthixol; Germany; Humans; Male; Middle Aged; Patient Readmission; Recurrence; Schizophrenia; Schizophrenic Psychology; Social Security | 1998 |
Response to high doses of citalopram in treatment-resistant obsessive-compulsive disorder.
Topics: Adult; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Buspirone; Citalopram; Clomipramine; Delusions; Drug Resistance; Female; Flupenthixol; Humans; Obsessive-Compulsive Disorder; Recurrence; Treatment Outcome | 1998 |
Further observations on the duration of depot neuroleptic maintenance therapy in schizophrenia.
Topics: Delayed-Action Preparations; Flupenthixol; Fluphenazine; Humans; Recurrence; Schizophrenia; Thioxanthenes | 1979 |
Rationalizing neuroleptic polypharmacy in chronic schizophrenics: effects of changing to a single depot preparation.
Topics: Administration, Oral; Antipsychotic Agents; Chronic Disease; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Flupenthixol; Fluphenazine; Humans; Injections, Intramuscular; Male; Middle Aged; Neurologic Examination; Psychiatric Status Rating Scales; Recurrence; Schizophrenia; Schizophrenic Psychology | 1992 |
Acute schizophrenia.
Topics: Acute Disease; Antipsychotic Agents; Flupenthixol; Humans; Kinetics; Prolactin; Recurrence; Schizophrenia | 1985 |
The significance of depression in the prediction of relapse in chronic schizophrenia.
Topics: Adult; Depressive Disorder; Female; Flupenthixol; Fluphenazine; Humans; Male; Middle Aged; Recurrence; Risk Factors; Schizophrenia; Schizophrenic Psychology; Time Factors | 1988 |
Fatal recurrence of neuroleptic malignant syndrome.
Topics: Adult; Death, Sudden; Diagnostic Errors; Flupenthixol; Humans; Male; Neuroleptic Malignant Syndrome; Recurrence; Virus Diseases | 1988 |
Schizophrenic relapse after drug withdrawal is predictable.
Topics: Adult; Aged; Clopenthixol; Female; Flupenthixol; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Psychometrics; Recurrence; Schizophrenia; Schizophrenic Psychology; Substance Withdrawal Syndrome; Thioxanthenes | 1986 |
Management of the repeatedly suicidal patient.
Topics: Adolescent; Adult; Ambulatory Care; Female; Flupenthixol; Hospitalization; Humans; Recurrence; Suicide, Attempted | 1985 |
Flupenthixol decanoate--in treatment of out-patients.
Topics: Ambulatory Care; Female; Flupenthixol; Follow-Up Studies; Humans; Length of Stay; Male; Outpatient Clinics, Hospital; Paranoid Disorders; Psychotic Disorders; Recurrence; Schizophrenia; Thioxanthenes | 1974 |